AOTMiT: Transparency Council will evaluate drugs for schizophrenia and Hodgkin's lymphoma, among others

The agenda includes:

1 Prepare a position paper on the evaluation of the drug Reagila (cariprazinum) for the indication: schizophrenia in adult patients after ineffectiveness or in case of contraindications to therapy with other second-generation antipsychotic drugs.

2. Preparation of a position paper on the evaluation of the drug Tolutris (telmisartanum + amlodipini besilas + hydrochlorothiazidum) for the indication: in replacement therapy for the treatment of spontaneous blood pressure in adult patients whose blood pressure is adequately controlled during the simultaneous use of combination medicinal products containing 2 active substances: telmisartan and hydrochlorothiazide, and medicinal products containing 1 active substance amlodipine, administered in the same doses as in combination, but as separate tablets.

3 Prepare a position paper on the examination of the appropriateness of issuing reimbursement approvals for the medicinal product Calcort (deflazacort) for the indication: Duchenne muscular dystrophy.

4 Prepare a position paper to examine the appropriateness of issuing reimbursement approvals for the medicinal product Veoza (fezolinetantum) for the indication: moderate to severe vasomotor symptom (VMS) associated with menopause in patients undergoing prophylactic anti-estrogen hormone therapy based on tamoxifen for pre-invasive breast cancer.

5 Prepare a position paper on the examination of the appropriateness of issuing approvals for reimbursement of the medicinal product Proglicem (diazoxidum) for the indications: insulinoma, hyperinsulinemic hypoglycemia, congenital hyperinsulinism, hypoglycemia-hyperammonemia syndrome, MEN2 syndrome, hypoglycemia unspecified, other hypoglycemias.

6 Prepare an opinion on the draft health policy program of the local government unit "Municipal Health Policy Program on prevention of meningococcal infections in Kozy for 2025-2026".

7 Prepare an opinion on the draft health policy program of the local government unit "Health policy program in the field of rehabilitation, physical therapy and physiotherapy for 2025-2027" (Stopnica municipality).

8 Prepare an opinion on the draft health policy program of the local government unit "Day Care Home in the Municipality of Krakow".

9. Preparation of an opinion on the reimbursement of the active substance brentuximab vedotin in the off-label indication: Hodgkin's lymphoma.

Source: AOTMiT